TissGeneSummary for NUDT10 |
Gene summary |
Basic gene information | Gene symbol | NUDT10 |
Gene name | nudix (nucleoside diphosphate linked moiety X)-type motif 10 | |
Synonyms | APS2|DIPP3a|hDIPP3alpha | |
Cytomap | UCSC genome browser: Xp11.23 | |
Type of gene | protein-coding | |
RefGenes | NM_153183.2, | |
Description | DIPP-3-alphaDIPP3-alphadiadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 3-alphadiadenosine hexaphosphate hydrolase (AMP-forming)diphosphoinositol polyphosphate phosphohydrolase 3-alphadiphosphoinositol polyphosphate phosphohydrolase type 3 alphahAp | |
Modification date | 20141207 | |
dbXrefs | MIM : 300527 | |
HGNC : HGNC | ||
Ensembl : ENSG00000122824 | ||
HPRD : 17651 | ||
Vega : OTTHUMG00000021530 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_NUDT10 | |
BioGPS: 170685 | ||
Pathway | NCI Pathway Interaction Database: NUDT10 | |
KEGG: NUDT10 | ||
REACTOME: NUDT10 | ||
Pathway Commons: NUDT10 | ||
Context | iHOP: NUDT10 | |
ligand binding site mutation search in PubMed: NUDT10 | ||
UCL Cancer Institute: NUDT10 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | ||
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Testis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCT | |
Reference showing the relevant tissue of NUDT10 | ||
Description by TissGene annotations | Protective TissGene in OS |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for NUDT10 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
LUSC | -0.612063191 | -2.497231818 | 1.885168627 | 2.52E-08 | 7.57E-08 |
PRAD | 2.033619351 | 3.467578966 | -1.433959615 | 8.39E-14 | 6.27E-12 |
KIRC | -2.832989089 | 0.306885911 | -3.139875 | 2.54E-31 | 5.42E-30 |
KICH | -3.871107034 | 0.166824966 | -4.037932 | 1.28E-16 | 3.97E-15 |
LIHC | -4.495969034 | -1.122075034 | -3.373894 | 1.06E-25 | 2.94E-23 |
KIRP | -2.931021034 | 0.114225841 | -3.045246875 | 6.31E-16 | 2.08E-14 |
COAD | -2.692682572 | -0.979840265 | -1.712842308 | 3.16E-06 | 1.60E-05 |
STAD | -2.899080409 | -0.825958534 | -2.073121875 | 6.38E-07 | 1.11E-05 |
ESCA | -3.030171034 | -0.752116488 | -2.278054545 | 0.00175 | 0.02126776 |
BLCA | -2.138018402 | -0.331802613 | -1.806215789 | 0.00239 | 0.014806017 |
Top |
TissGene-miRNA for NUDT10 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for NUDT10 |
TissGeneSNV for NUDT10 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.T93M | UCEC | 1 |
p.G147D | STAD | 1 |
p.E102V | KIRP | 1 |
p.A20V | UCEC | 1 |
p.S159L | SARC | 1 |
p.V82I | STAD | 1 |
p.T8I | KIRP | 1 |
p.E102* | CESC | 1 |
p.V36A | KIRC | 1 |
p.P42Q | HNSC | 1 |
p.E14K | CESC | 1 |
p.E32K | BLCA | 1 |
p.P58T | LIHC | 1 |
p.V82I | BRCA | 1 |
Top |
TissGeneCNV for NUDT10 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for NUDT10 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | ChiTaRs | NA | AU125362 | NUDT10-TTC37 | chrX:51079353 | chr5:94877007 |
Top |
TissGeneNet for NUDT10 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for NUDT10 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for NUDT10 |
TissGeneDrug for NUDT10 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for NUDT10 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0085409 | Polyendocrinopathies, Autoimmune | 6 | BeFree |
umls:C0011854 | Diabetes Mellitus, Insulin-Dependent | 5 | BeFree |
umls:C0085859 | Polyglandular Type I Autoimmune Syndrome | 3 | BeFree |
umls:C0178468 | Autoimmune thyroid disease | 3 | BeFree |
umls:C0376358 | Malignant neoplasm of prostate | 3 | GAD |
umls:C0004364 | Autoimmune Diseases | 2 | BeFree |
umls:C0040147 | Thyroiditis | 2 | BeFree |
umls:C0042900 | Vitiligo | 1 | BeFree |
umls:C0085292 | Stiff-Person Syndrome | 1 | BeFree |
umls:C0271737 | Addison's disease due to autoimmunity | 1 | BeFree |
umls:C1847835 | VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | 1 | BeFree |
umls:C2103602 | Autoimmune Primary Adrenal Insufficiency | 1 | BeFree |
umls:C3494489 | Autoimmune polyendocrinopathy syndrome, type 1 | 1 | BeFree |